(Q24250541)

English

Pharmaceutical considerations in the use of tetrandrine to treat silicosis

chapter published in 1995

In more languages

edit

Statements

1 reference

19 July 2017

Silica and silica-induced lung diseases

1 reference

19 July 2017

Pharmaceutical considerations in the use of tetrandrine to treat silicosis (English)

1 reference

11 July 2017

NIOSH Respiratory Health Division

object named as

DRDS

1 reference

25 September 2023

2 references

19 July 2017

29 March 2020

2 references

19 July 2017

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

1 reference

29 March 2020

5

0 references

Ann F. Hubbs

series ordinal

4

object named as

Hubbs-A

1 reference

3

Ma-JY

1 reference

1

Ma-JK

1 reference

Chao-H

2

1 reference

stated in

NIOSHTIC-2

language of work or name

English

1 reference

based on heuristic

inferred from title

process of elimination

publication date

20 December 1995

1 reference

stated in

NIOSHTIC-2

published in

Silica and silica induced lung diseases

1 reference

stated in

NIOSHTIC-2

performing organization

The Center for Construction Research and Training

object named as

Center to Protect Workers' Rights

1 reference

stated in

NIOSHTIC-2

retrieved

2 February 2024

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

funding scheme

cooperative agreement

1 reference

stated in

NIOSHTIC-2

retrieved

25 September 2023

Identifiers

NIOSHTIC-2 ID

00240948

0 references

(Q24250541)

Pharmaceutical considerations in the use of tetrandrine to treat silicosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)